#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	698	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1028	36.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	290	292	ACG	46;47;48	A;C;G	46;47;48	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	698	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1028	36.5	0	.	p	.	0	T209S	NONSYN	625	627	ACT	830	832	TCT	33;32;32	T;C;T	33;32;32	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	T879G	SNP	879	879	T	22	22	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	G880A	SNP	880	880	G	23	23	A	3	A	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	A888G	SNP	888	888	A	31	31	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	C897G	SNP	897	897	C	40	40	G	9	G	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	T898C	SNP	898	898	T	41	41	C	9	C	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	G906T	SNP	906	906	G	49	49	T	24	T	24	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	G908A	SNP	908	908	G	51	51	A	25	A	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	A918T	SNP	918	918	A	61	61	T	31	T	31	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	A943G	SNP	943	943	A	86	86	G	63	G	63	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	430	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	145	29.3	0	.	n	.	0	G991T	SNP	991	991	G	134	134	T	41	T	40	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1420	1422	AGC	53;56;55	A,G;G;C	38,15;55;55	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	1	SNP	p	R234F	1	.	.	700	702	TTC	895	897	TTC	139;139;136	T;T;C	139;139;135	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1195	1197	CGT	122;122;123	C;G;T	122;122;123	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	0	HET	.	.	.	C261T	.	261	261	C	456	456	C	112	C,T	69,42	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	0	HET	.	.	.	T999C	.	999	999	T	1194	1194	T	117	T,C	68,49	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2646	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1591	87.3	0	HET	.	.	.	T180C	.	180	180	T	375	375	T	60	T,C	30,26	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	980	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1743	30.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1542	1544	AAA	17;17;17	A;A;A	17;17;16	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1374	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1815	40.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1276	1278	GAA	48;48;47	G;A;A	47;47;45	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	338	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	883	20.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1020	PmrB_1	1092	1092	99.18	PmrB_1.l15.c17.ctg.1	1485	37.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	203	205	CGT	37;37;37	C;G;T	37;37;37	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1020	PmrB_1	1092	1092	99.18	PmrB_1.l15.c17.ctg.1	1485	37.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1046	1048	GGC	51;49;47	G;G;C	50;48;47	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1524	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1973	41.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	183	185	AGC	17;19;19	A;G;C	17;19;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1524	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1973	41.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	585	587	CTA	38;38;39	C;T;A	38;38;39	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1524	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1973	41.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1104	1106	CAA	39;42;46	C;A;A	39;41;45	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1524	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1973	41.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1203	1205	GGT	60;60;60	G;G;T	60;60;60	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1524	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1973	41.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1773	1775	GTT	31;27;25	G;T;T	31;27;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	792	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1586	26.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	594	596	GAA	26;26;24	G;A;A	26;26;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	792	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1586	26.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	774	776	ACC	14;14;14	A;C;C	14;14;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	792	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1586	26.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	894	896	ACT	15;15;14	A;C;T	15;15;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	792	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1586	26.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1284	1286	ATC	20;21;22	A;T;C	20;20;22	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	836	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1355	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	14	TEM_1+	858	112	98.21	TEM_1+.l6.c4.ctg.1	112	2.4	0	.	p	.	0	M67I	NONSYN	199	201	ATG	79	81	ATT	1;1;1	A;T;T	1;1;0	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	44	acrB	3147	141	91.49	acrB.l15.c4.ctg.1	143	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2386	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3497	36.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	465	467	ATC	45;45;45	A;T;C	45;43;45	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2386	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3497	36.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2178	2180	AAG	26;25;25	A;A;G	26;25;25	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	962	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1362	36.4	0	.	p	.	0	A22V	NONSYN	64	66	GCC	182	184	GTC	14;14;14	G;T;C	14;14;14	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	962	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1362	36.4	0	.	p	.	0	S269C	NONSYN	805	807	AGC	923	925	TGC	49;48;49	T;G;C	49;48;49	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	174	174	T	26	T	26	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	480	482	GAC	48;51;49	G;A;C	47;51;49	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	756	758	TTA	19;19;19	T;T;A	18;18;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1833	1835	AAT	72;72;73	A;A;T	72;72;73	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1947	1949	AGT	33;29;26	A;G;T	33;29;26	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2346	2348	GTG	37;38;36	G;T;G	37;38;36	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2914	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3350	46.4	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2901	2903	AAG	53;51;53	A;A;G	53;50;51	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	746	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1049	38.2	1	SNP	p	R45C	0	.	.	133	135	CGC	326	328	CGC	46;46;44	C;G;C	45;46;44	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	612	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1070	30.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	307	309	TTC	46;46;47	T;T;C	46;46;47	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	612	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1070	30.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	571	573	GGG	45;45;45	G;G;G	45;45;45	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	800	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1153	37.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	590	592	CTT	49;48;49	C;T;T	49;48;49	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2560	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3132	43.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2095	2097	GCA	62;61;61	G;C;A	62;61;61	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2560	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3132	43.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2356	2358	ACC	58;58;61	A;C;C	58;57;60	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2560	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3132	43.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2665	2667	GCC	37;40;38	G;C;C	37;40;38	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	303	305	GCT	10;12;12	G;C;T	10;12;12	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	423	425	GAG	5;4;4	G;A;G	5;4;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	459	461	TGC	9;10;11	T;G;C,T	9;10;10,1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	642	644	GTT	21;22;23	G;T;T	21;21;23	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	792	794	CAC	19;20;20	C;A;C	19;20;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1077	1079	ATG	34;35;40	A;T;G	34;35;38	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2369	27.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2073	2075	CGC	20;21;20	C;G;C	19;21;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	490	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1198	22.0	0	.	p	.	0	S221T	NONSYN	661	663	AGC	862	864	ACC	11;10;9	A;C;C	11;10;9	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	490	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1198	22.0	0	.	p	.	0	P225S	NONSYN	673	675	CCG	874	876	TCG	12;11;13	T;C;G	12;11;13	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	450	baeR	723	723	97.79	baeR.l6.c4.ctg.1	1109	21.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	824	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1590	27.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1299	1301	AAA	18;18;18	A;A;A	17;18;18	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	824	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1590	27.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1311	1313	GAG	13;15;15	G;A;G	12;13;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	824	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1590	27.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1317	1319	CAC	16;16;16	C;A;C	15;14;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	824	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1590	27.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1371	1373	GAG	14;13;13	G;A;G	14;13;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1220	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1783	36.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	838	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1133	39.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	820	cysB	975	975	99.38	cysB.l15.c17.ctg.1	1405	31.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1006	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1320	38.7	0	.	p	.	0	W42C	NONSYN	124	126	TGG	163	165	TGT	23;20;19	T;G;T,G	23;20;17,1	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1006	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1320	38.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	694	696	GTC	43;42;41	G;T,G;C	42;40,1;41	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1296	emrB	1539	1539	99.81	emrB.l15.c17.ctg.1	1947	35.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1014	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1591	34.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	826	828	AGC	19;19;19	A;G;C	19;19;18	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	30	emrE_1	333	83	96.39	emrE_1.l15.c4.ctg.1	99	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	874	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1483	31.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	724	726	AGG	29;30;30	A;G;G	29;30;30	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	874	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1483	31.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1114	1116	GAC	18;19;19	G;A;C	18;19;19	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	550	emrR	531	531	100.0	emrR.l15.c30.ctg.1	963	30.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1256	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1978	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	622	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1009	33.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	381	383	CTG	36;36;36	C;T;G	36;36;36	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	322	324	ATA	13;12;12	A;T;A	13;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	334	336	GTA	13;13;13	G;T;A	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	487	489	ACG	30;29;32	A;C;G	30;29;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	550	552	GAA	36;36;36	G;A;A	36;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	589	591	GCT	39;39;41	G;C;T	39;39;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	607	609	GAT	34;34;34	G;A;T	34;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	694	696	TCA	32;32;31	T;C;A	32;32;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	823	825	CAG	21;22;23	C;A;G	21;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	961	963	GTT	19;19;19	G;T;T	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	931	97.31	evgS.l15.c4.ctg.1	1141	28.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1117	1119	GAT	7;7;7	G;A;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	25;26;26	A;A;A	25;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	932	934	CAT	38;37;37	C;A;T	38;37;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	986	988	CAT	20;21;22	C;A;T	20;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1004	1006	AGA	25;25;26	A;G;A	25;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1019	1021	AAT	23;24;24	A;A;T	23;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1166	1168	TCC	19;20;19	T;C;C	19;20;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1331	1333	ATT	26;26;27	A;T;T	26;26;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1352	1354	GAT	21;20;20	G;A;T	21;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1466	1468	GTT	42;40;40	G;T;T	42;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1751	1753	CAC	39;38;36	C;A;C	38;38;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	2490	97.87	evgS.l15.c4.ctg.2	2673	40.4	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2489	2491	AAC	21;21;21	A;A;C	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2660	evgS	3594	174	95.4	evgS.l15.c4.ctg.3	174	14.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	158	160	AAT	11;10;10	A;A;T	11;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	692	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1227	30.3	1	SNP	p	P64H	0	.	.	190	192	CCA	369	371	CCA	64;62;62	C;C;A	64;62;55	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	692	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1227	30.3	1	SNP	p	P64A	0	.	.	190	192	CCA	369	371	CCA	64;62;62	C;C;A	64;62;55	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	692	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1227	30.3	1	SNP	p	P64R	0	.	.	190	192	CCA	369	371	CCA	64;62;62	C;C;A	64;62;55	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	692	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1227	30.3	1	SNP	p	P64L	0	.	.	190	192	CCA	369	371	CCA	64;62;62	C;C;A	64;62;55	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	692	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1227	30.3	1	SNP	p	P64S	0	.	.	190	192	CCA	369	371	CCA	64;62;62	C;C;A	64;62;55	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	580	gadE	528	528	100.0	gadE.l15.c4.ctg.1	933	33.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	160	gadW	729	137	97.08	gadW.l15.c30.ctg.1	137	27.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	622	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1178	28.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	310	312	TTA	36;37;38	T;T;A	36;36;38	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	622	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1178	28.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	388	390	ATT	27;25;21	A;T;T	27;25;21	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	622	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1178	28.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	889	891	GGA	25;25;24	G;G;A	25;25;23	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	622	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1178	28.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	895	897	CCG	24;23;23	C;C;G	24;23;23	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2245	2247	GAA	31;31;29	G;A;A	31;30;29	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	S83I	0	.	.	247	249	TCG	460	462	TCG	47;47;48	T;C;G	47;47;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	S83W	0	.	.	247	249	TCG	460	462	TCG	47;47;48	T;C;G	47;47;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	S83L	0	.	.	247	249	TCG	460	462	TCG	47;47;48	T;C;G	47;47;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	D87N	0	.	.	259	261	GAC	472	474	GAC	43;44;43	G;A;C	43;43;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	D87V	0	.	.	259	261	GAC	472	474	GAC	43;44;43	G;A;C	43;43;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	D87G	0	.	.	259	261	GAC	472	474	GAC	43;44;43	G;A;C	43;43;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	472	474	GAC	43;44;43	G;A;C	43;43;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2310	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3069	40.5	1	SNP	p	D87H	0	.	.	259	261	GAC	472	474	GAC	43;44;43	G;A;C	43;43;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136E	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136I	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136L	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136C	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136G	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136S	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2046	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2790	39.3	1	SNP	p	R136H	0	.	.	406	408	CGC	622	624	CGC	39;39;39	C;G;C	38;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	398	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1068	20.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	424	426	CCG	30;29;30	C;C;G	30;29;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	398	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1068	20.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	577	579	GCC	23;21;21	G;C;C	23;21;21	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1028	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1263	43.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	182	184	TCA	33;33;32	T;C;A	33;33;32	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	366	marA	384	384	99.74	marA.l15.c4.ctg.1	785	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	529	531	AGC	16;15;11	A;G;C	16;14;11	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	631	633	CAT	7;6;6	C;A;T	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	V45E	0	.	.	133	135	GTG	355	357	GTG	32;31;31	G;T;G	32;31;31	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	I49S	0	.	.	145	147	ATC	367	369	ATC	29;29;28	A;T,C;C	29;28,1;28	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	A70T	0	.	.	208	210	GCA	430	432	GCA	18;19;19	G;C;A	18;18;19	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R73C	0	.	.	217	219	CGT	439	441	CGT	19;20;20	C;G;T	18;19;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R73S	0	.	.	217	219	CGT	439	441	CGT	19;20;20	C;G;T	18;19;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R77L	0	.	.	229	231	CGC	451	453	CGC	21;21;21	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R77C	0	.	.	229	231	CGC	451	453	CGC	21;21;21	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	L78M	0	.	.	232	234	CTG	454	456	CTG	21;20;20	C;T;G	21;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R94S	0	.	.	280	282	CGC	502	504	CGC	13;13;13	C;G;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	R94H	0	.	.	280	282	CGC	502	504	CGC	13;13;13	C;G;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	218	marR	435	435	97.7	marR.l6.c17.ctg.1	820	14.2	1	SNP	p	V96E	0	.	.	286	288	GTA	508	510	GTA	15;15;15	G;T;A	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	S7F	NONSYN	19	21	TCC	200	202	TTC	12;12;12	T;T;C	12;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	287	289	ATC	14;13;12	A;T;C	14;13;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	E42A	NONSYN	124	126	GAA	305	307	GCC	5;5;5	G;C;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	N43V	NONSYN	127	129	AAT	308	310	GTG	5;5;5	G;T;G	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	E52D	NONSYN	154	156	GAG	335	337	GAT	10;10;10	G;A;T	10;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	N59T	NONSYN	175	177	AAC	356	358	ACC	14;13;12	A;C;C	13;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	I68L	NONSYN	202	204	ATA	383	385	TTA	15;14;14	T;T;A	15;14;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	524	526	CAG	37;38;37	C;A;G	37;38;37	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	D128A	NONSYN	382	384	GAC	563	565	GCC	21;20;20	G;C;C	21;20;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	S163A	NONSYN	487	489	TCG	668	670	GCG	30;30;30	G;C;G	30;30;30	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	L231V	NONSYN	691	693	CTT	872	874	GTT	31;31;32	G;T;T	23;29;29	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	656	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1571	22.4	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1034	1034	C	18	C	18	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	682	98.24	mdtA.l15.c17.ctg.1	857	27.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	570	96.49	mdtA.l15.c17.ctg.2	629	15.3	0	.	p	.	0	V12trunc	TRUNC	34	34	G	98	98	G	23	G	23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	570	96.49	mdtA.l15.c17.ctg.2	629	15.3	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	155	157	CAG	13;12;12	C;A;G	12;12;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	570	96.49	mdtA.l15.c17.ctg.2	629	15.3	0	.	p	.	0	T83I	NONSYN	247	249	ACC	305	307	ATC	15;14;14	A;T;C	15;13;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	570	96.49	mdtA.l15.c17.ctg.2	629	15.3	0	.	p	.	0	I99M	NONSYN	295	297	ATA	353	355	ATG	10;10;10	A;T;G	10;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	642	mdtA	1248	570	96.49	mdtA.l15.c17.ctg.2	629	15.3	0	.	p	.	0	A130T	NONSYN	388	390	GCC	446	448	ACC	20;21;21	A;C;C	20;21;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2026	2028	ACC	46;46;46	A;C;C	46;46;46	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2419	2421	CAA	21;20;19	C;A;A,G	20;20;17,1	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2587	2589	ATT	20;20;19	A;T;T	20;20;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2671	2673	GTT	33;33;32	G;T;T	33;33;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2779	2781	GAG	21;21;18	G;A;G	21;20;18	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3007	3009	ATG	26;27;27	A;T;G	26;27;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2256	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3497	34.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3142	3144	GAT	34;35;34	G;A;T	33;34;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1826	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3216	30.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	228	230	ATG	17;17;17	A;T;G	17;17;17	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1826	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3216	30.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	714	716	ATC	26;26;29	A;T;C	25;26;29	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1826	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3216	30.1	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3030	3032	CAC	5;5;5	C;A;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	988	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1769	30.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	152	154	GAA	13;13;12	G;A;A	13;13;12	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	988	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1769	30.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	821	823	GCG	25;25;25	G;C;G	25;25;25	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	988	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1769	30.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1163	1165	ATC	42;41;44	A;T;C	42;41;44	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	988	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1769	30.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1466	1468	TTT	43;44;44	T;T;T	43;44;44	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1146	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1570	39.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2650	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3534	40.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1082	1084	ACC	30;30;32	A;C;C	30;30;32	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2650	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3534	40.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2324	2326	GAC	51;50;51	G;A;C	51;50;51	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	914	mdtG	1227	1047	99.43	mdtG.l6.c17.ctg.1	1499	26.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	643	645	ATC	20;20;21	A;T;C	19;20;21	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	914	mdtG	1227	182	99.45	mdtG.l6.c17.ctg.2	532	16.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	170	172	GGA	11;9;8	G;G;A	11;9;8	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	732	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1355	27.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	400	402	TGT	34;34;34	T;G;T	34;34;34	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	732	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1355	27.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	970	972	TTG	28;27;26	T;T;G	28;26;26	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	732	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1355	27.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1180	1182	ACG	19;19;18	A;C;G	19;19;18	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	922	mdtL	1176	1176	98.21	mdtL.l15.c30.ctg.1	1601	31.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	743	745	TCC	27;29;29	T;C;C	24;29;29	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	740	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1446	27.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	567	569	ATT	28;28;28	A;T;T	28;28;28	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	107	109	ATG	17;19;20	A;T;G	17;19;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	173	175	ATC	27;27;28	A;T;C	26;25;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	422	424	CGC	42;42;42	C;G;C	42;42;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	788	790	AGC	42;42;42	A;G;C	42;41;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	989	991	GTG	34;33;32	G;T;G	34;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1052	1054	AAC	14;13;12	A;A;C	14;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1097	1099	GTC	25;25;25	G;T;C	25;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1127	1129	ATA	31;31;32	A;T;A	31;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1235	1237	TCT	34;34;34	T;C;T	34;34;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1622	1624	GCG	28;28;29	G;C,T;G	27;26,1;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2306	35.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1835	1837	ATC	44;44;45	A;T;C	43;44;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	384	384	T	39	T	38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	567	569	GCG	39;37;37	G;C;G	38;35;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	741	743	ACC	36;37;36	A;C;C	36;36;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	813	815	CGC	38;35;34	C;G;C	38;35;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	930	932	GCT	30;31;32	G;C;T	30;31;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1014	1016	AAA	15;13;13	A;A;A	15;13;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1032	1034	CGA	15;16;16	C;G;A	15;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1197	1199	GCC	15;17;17	G;C;C	14;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1209	1211	GAT	24;26;27	G;A;T	24;26;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	956	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1690	29.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1626	1628	GCT	10;10;10	G;C;T	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2434	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3858	33.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1514	1516	AAG	26;26;26	A;A;G	26;25;26	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2434	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3858	33.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2591	2593	CTG	27;27;27	C;T;G	27;27;27	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	216	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	168	34.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1640	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2117	41.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1001	1003	AAC	36;36;36	A;A;C	36;36;36	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1640	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2117	41.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1547	1549	ATA	51;52;52	A;T;A	51;52;52	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1184	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1646	38.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1298	1300	GAT	50;48;50	G;A;T	50;47;50	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1184	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1646	38.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1301	1303	CTG	50;50;51	C;T;G	50;50;51	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	270	272	TGT	36;35;35	T;G;T	36;35;35	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	540	542	ACC	34;34;34	A;C;C	33;34;34	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	750	752	GAC	16;16;16	G;A;C	16;16;16	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	1	SNP	p	R15C	0	.	.	43	45	CGC	234	236	CGC	58;56;58	C;G,T;C	57;54,1;57	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	1	SNP	p	S33R	0	.	.	97	99	AGC	288	290	AGC	33;33;31	A;G;C	33;33;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	1	SNP	p	G131D	0	.	.	391	393	GGC	582	584	GGC	29;28;29	G;G;C	29;28;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	1	SNP	p	R203C	0	.	.	607	609	CGT	798	800	CGT	21;23;24	C;G;T	21;23;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	516	nfsA	723	723	99.03	nfsA.l15.c17.ctg.1	1106	25.0	1	SNP	p	R203L	0	.	.	607	609	CGT	798	800	CGT	21;23;24	C;G;T	21;23;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1248	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1520	44.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1150	1152	GAG	51;51;51	G;A;G	51;51;51	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1248	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1520	44.1	1	SNP	p	G141E	0	.	.	421	423	GGT	637	639	GGT	62;59;61	G;G;T	62;59;61	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1248	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1520	44.1	1	SNP	p	G141D	0	.	.	421	423	GGT	637	639	GGT	62;59;61	G;G;T	62;59;61	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1248	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1520	44.1	1	SNP	p	R154D	0	.	.	460	462	CGT	676	678	CGT	60;59;59	C;G;T	60;59;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1248	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1520	44.1	1	SNP	p	R154A	0	.	.	460	462	CGT	676	678	CGT	60;59;59	C;G;T	60;59;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1952	parC_2	2259	2259	99.29	parC_2.l15.c17.ctg.1	2555	40.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1775	1777	TCG	43;43;45	T;C;G	42;42;44	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1952	parC_2	2259	2259	99.29	parC_2.l15.c17.ctg.1	2555	40.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2390	2392	AAC	29;28;28	A;A;C	29;28;28	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1952	parC_2	2259	2259	99.29	parC_2.l15.c17.ctg.1	2555	40.9	1	SNP	p	A85T	0	.	.	253	255	GCG	404	406	GCG	38;39;41	G;C;G	36;37;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1952	parC_2	2259	2259	99.29	parC_2.l15.c17.ctg.1	2555	40.9	1	SNP	p	D111H	0	.	.	331	333	GAT	482	484	GAT	33;33;33	G;A;T	33;32;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1952	parC_2	2259	2259	99.29	parC_2.l15.c17.ctg.1	2555	40.9	1	SNP	p	S129P	0	.	.	385	387	TCC	536	538	TCC	50;51;50	T;C;C	50;51;49	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	1354	parE_1	1893	1746	97.48	parE_1.l15.c30.ctg.1	1965	34.4	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1279	1281	GAT	58;54;54	G;A;T	58;54;54	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	1354	parE_1	1893	148	97.97	parE_1.l15.c30.ctg.2	148	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1218	patA	1380	1380	99.86	patA.l15.c17.ctg.1	1832	35.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1332	1334	GAT	49;48;49	G;A;T	49;47;49	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	V146F	0	.	.	436	438	GTT	637	639	GTT	53;52;53	G;T;T	53;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1738	1740	CAG	43;40;40	C;A;G	43;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1738	1740	CAG	43;40;40	C;A;G	43;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1777	1779	CAC	41;42;42	C;A;C	41;42;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1786	1788	CGT	41;42;41	C;G;T	41;42;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1786	1788	CGT	41;42;41	C;G;T	41;42;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1792	1794	TCC	43;44;43	T;C;C	43;44;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1798	1800	CTC	41;40;39	C;T;C,T	41;40;38,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1888	1890	ACC	57;57;57	A;C;C	57;56;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1891	1893	CCT	58;58;58	C;C;T	58;58;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4252	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	51.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2260	2262	CGT	76;76;76	C;G;T	76;76;75	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	.	n	.	0	A226G	SNP	226	226	A	380	380	G	348	G	348	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	A794T	0	.	.	794	794	A	948	948	A	275	A	268	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	A794G	0	.	.	794	794	A	948	948	A	275	A	268	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	G926C	0	.	.	926	926	G	1080	1080	G	287	G	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	G926A	0	.	.	926	926	G	1080	1080	G	287	G	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	G926T	0	.	.	926	926	G	1080	1080	G	287	G	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	A1519G	0	.	.	1519	1519	A	1673	1673	A	293	A	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	A1519C	0	.	.	1519	1519	A	1673	1673	A	293	A	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	1	SNP	n	A1519T	0	.	.	1519	1519	A	1673	1673	A	293	A	287	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	G1002A	.	1002	1002	G	1156	1156	G	297	G,A	169,126	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	G1006C	.	1006	1006	G	1160	1160	G	296	G,C	171,121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	A79G	.	79	79	A	233	233	A	293	A,G	234,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	C719T	.	719	719	C	873	873	C	269	C,T	195,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	T273A	.	273	273	T	427	427	T	312	T,A	242,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	T1010C,G	.	1010	1010	T	1164	1164	T	294	T,C,G	175,114,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	C1038T	.	1038	1038	C	1192	1192	C	265	C,T	150,114	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	C183T	.	183	183	C	337	337	C	309	C,T	211,97	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	T90C	.	90	90	T	244	244	T	296	T,C	225,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	A250T	.	250	250	A	404	404	A	312	A,T	249,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	G474A	.	474	474	G	628	628	G	331	G,A	246,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	A253T	.	253	253	A	407	407	A	319	A,T	256,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10086	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1893	280.1	0	HET	.	.	.	C194T	.	194	194	C	348	348	C	335	C,T	262,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c30.ctg.1	829	29.1	1	SNP	p	R20H	0	.	.	58	60	CGC	242	244	CGC	39;40;40	C;G;C	38;40;40	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c30.ctg.1	829	29.1	1	SNP	p	G121D	0	.	.	361	363	GGT	545	547	GGT	49;50;49	G;G;T	49;50;49	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	358	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	746	25.8	1	SNP	p	A12S	0	.	.	34	36	GCA	234	236	GCA	48;49;49	G;C;A	48;49;49	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1414	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1870	40.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
